Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prostate Lesions”

91 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 91 results

Not applicableStudy completedNCT07533344
What this trial is testing

Ga-68 PSMA PET/CT vs mpMRI in Cognitive Prostate Biopsy

Who this might be right for
Prostate Cancer
Fatih Sultan Mehmet Training and Research Hospital 60
Not applicableWithdrawnNCT00611065
What this trial is testing

Imaging of Prostate Cancer Using Two-dimensional MR Spectroscopy and Diffusion Tensor Imaging

Who this might be right for
Prostate Lesions
University of California, Irvine
Not applicableLooking for participantsNCT05705921
What this trial is testing

Standard Moderately Hypofractionated RT vs. Ultra-hypofractionated Focal Lesion Ablative Microboost in Prostate Cancer

Who this might be right for
Prostate Cancer
The Netherlands Cancer Institute 484
Not applicableUnknownNCT03174054
What this trial is testing

The Value of PSMA-PET Compared With Multi-parametric MRI in the Detection Prostate Lesions

Who this might be right for
Prostate Cancer
Assuta Medical Center 70
Large-scale testing (Phase 3)Study completedNCT04102553
What this trial is testing

F-18-PSMA-1007 Versus F-18-Fluorocholine PET in Patients With Biochemical Recurrence

Who this might be right for
Prostate CancerProstate Cancer Recurrent
ABX advanced biochemical compounds GmbH 200
Large-scale testing (Phase 3)Study completedNCT00330759
What this trial is testing

Study of Denosumab vs. Zoledronic Acid to Treat Bone Metastases in Subjects With Advanced Cancer or Multiple Myeloma.

Who this might be right for
Bone Metastases
Amgen 1,779
Not applicableUnknownNCT01913717
What this trial is testing

Short-term High Precision Radiotherapy for Early Prostate Cancer With Concomitant Boost on the Dominant Lesion

Who this might be right for
Adenocarcinoma of Prostate
European Institute of Oncology 65
Not applicableActive Not RecruitingNCT06822491
What this trial is testing

Early Magnetic Resonance Imaging Response of the Dominant Intraprostatic Lesion After Online Adaptive Stereotactic Body Radiotherapy for Localized Prostate Cancer and Correlation With Prostate Specific Antigen Response

Who this might be right for
Prostate CarcinomaLocalized Prostate AdenocarcinomaStereotactic Body Radiotherapy+3 more
University of Zurich 28
Not applicableStudy completedNCT00807820
What this trial is testing

Phase I Targeting Dominant Intraprostatic Lesion Using MR Spectroscopy and HDR Brachytherapy

Who this might be right for
Prostate Cancer
University of California, San Francisco 10
Testing effectiveness (Phase 2)Looking for participantsNCT05223803
What this trial is testing

TERPS Trial for de Novo Oligometastic Prostate Cancer

Who this might be right for
Prostate CancerOligometastatic Disease
University of Maryland, Baltimore 122
Post-approval studies (Phase 4)Study completedNCT00029224
What this trial is testing

Treatment With Zoledronic Acid in Patients With Breast Cancer, Multiple Myeloma, and Prostate Cancer With Cancer Related Bone Lesions

Who this might be right for
Breast CancerMultiple MyelomaProstate Cancer
Novartis 500
Not applicableStudy completedNCT00427817
What this trial is testing

PRO-STATE:Search for a Protein Profile Corresponding to Fast-developing Lesions and Characterization of Implicated Proteins in Prostate Carcinoma

Who this might be right for
Adenoma, Prostatic
University Hospital, Grenoble 300
Not applicableStudy completedNCT06461689
What this trial is testing

Comparison of Changes in Tumor Burden in 68Ga-PSMA-11 PET/CT and 177Lu-PSMA SPECT/CT in Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Prostate Cancer Metastatic
Central Hospital, Nancy, France 80
Not applicableLooking for participantsNCT06430749
What this trial is testing

Targeted Microwave Tissue Coagulation for Prostate Cancer

Who this might be right for
Prostate Cancer
Osamu Ukimura 65
Not applicableStudy completedNCT01657942
What this trial is testing

Focal MR-Guided Focused Ultrasound Treatment of Localized Intermediate Risk Prostate Lesions

Who this might be right for
Localized Intermediate Risk Prostate Lesions
InSightec 101
Not applicableNot Yet RecruitingNCT07355504
What this trial is testing

Prostate Cancer Early Detection Using Serial MRI Examinations

Who this might be right for
Prostate Cancer
University Hospital, Grenoble 380
Testing effectiveness (Phase 2)Study completedNCT03384199
What this trial is testing

Dose Escalation Using Fiducial Markers in Image Guided Volumetric Modulated Arc Therapy to the Focal Lesion Micro Boost of Localized Prostate Cancer

Who this might be right for
Prostatic Adenocarcinoma
Kasr El Aini Hospital 30
Not applicableStudy completedNCT06116344
What this trial is testing

Improving Prostate Lesion Classification and Development of a PI-RADS 3 Classifier

Who this might be right for
Prostate Cancer
Paracelsus Medical University 173
Not applicableStudy completedNCT03030625
What this trial is testing

VMAT for Dominant Intraprostatic Lesion

Who this might be right for
Prostate Cancer
Fundación de Investigación Biomédica - Hospital Universitario de La Princesa 30
Not applicableUnknownNCT05919524
What this trial is testing

SBRT With Focal Dose Escalation on DIL in Localized Prostate Cancer

Who this might be right for
Prostate Adenocarcinoma
Almudena Zapatero 27
Load More Results